C57BL/6JCya-Pcsk9em1/Cya
Common Name
Pcsk9-KO
Product ID
S-KO-00068
Backgroud
C57BL/6JCya
Strain ID
KOCMP-100102-Pcsk9-B6J-VB
When using this mouse strain in a publication, please cite “Pcsk9-KO Mouse (Catalog S-KO-00068) were purchased from Cyagen.”
Product Type
Age
Genotype
Sex
Quantity
Basic Information
Strain Name
Pcsk9-KO
Strain ID
KOCMP-100102-Pcsk9-B6J-VB
Gene Name
Product ID
S-KO-00068
Gene Alias
FH3, HCHOLA3, Narc1, PC9
Background
C57BL/6JCya
NCBI ID
Modification
Conventional knockout
Chromosome
Chr 4
Phenotype
Datasheet
Application
--
Strain Description
Ensembl Number
ENSMUST00000049507
NCBI RefSeq
NM_153565
Target Region
Exon 2~3
Size of Effective Region
~3.1 kb
Overview of Gene Research
PCSK9, also known as proprotein convertase subtilisin/kexin type 9, is a proteolytic enzyme that plays a pivotal role in lipid metabolism. It indirectly regulates serum LDL cholesterol (LDL-C) by causing the destruction of LDL receptors on the surface of liver hepatocytes. This regulation of LDL-C levels is crucial for cardiovascular health [1,3,4].
Deleting the PCSK9 gene in mouse cancer cells substantially attenuates or prevents their growth in mice in a manner that depends on cytotoxic T cells. It also enhances the efficacy of immune therapy targeted at the checkpoint protein PD1. This shows that inhibiting PCSK9 can boost the response of tumours to immune checkpoint therapy through a mechanism independent of its cholesterol-regulating functions [2].
In conclusion, PCSK9 is essential in regulating LDL-C levels, thus having a significant impact on cardiovascular health. The gene knockout mouse models have revealed an unexpected role of PCSK9 in cancer, specifically in modulating the response to immune checkpoint therapy. These findings suggest that PCSK9 could be a potential target for enhancing cancer immunotherapy as well as treating hypercholesterolemia-related cardiovascular diseases [1,2,3,4].
References:
1. Roth, Eli M, Davidson, Michael H. . PCSK9 Inhibitors: Mechanism of Action, Efficacy, and Safety. In Reviews in cardiovascular medicine, 19, S31-S46. doi:10.3909/ricm19S1S0002. https://pubmed.ncbi.nlm.nih.gov/30207556/
2. Liu, Xinjian, Bao, Xuhui, Hu, Mengjie, Li, Fang, Li, Chuan-Yuan. 2020. Inhibition of PCSK9 potentiates immune checkpoint therapy for cancer. In Nature, 588, 693-698. doi:10.1038/s41586-020-2911-7. https://pubmed.ncbi.nlm.nih.gov/33177715/
3. Melendez, Quantil M, Krishnaji, Sreevidhya T, Wooten, Catherine J, Lopez, Dayami. 2017. Hypercholesterolemia: The role of PCSK9. In Archives of biochemistry and biophysics, 625-626, 39-53. doi:10.1016/j.abb.2017.06.001. https://pubmed.ncbi.nlm.nih.gov/28587771/
4. Blanchard, Valentin, Khantalin, Ilya, Ramin-Mangata, Stéphane, Nativel, Brice, Lambert, Gilles. 2018. PCSK9: from biology to clinical applications. In Pathology, 51, 177-183. doi:10.1016/j.pathol.2018.10.012. https://pubmed.ncbi.nlm.nih.gov/30522786/
Quality Control Standard
Sperm Test
Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.
Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.
Environmental Standards:SPF
Available Region:Global
Source:Cyagen
Contact Us
Connect with our experts for your custom animal model needs. Please fill out the form below to start a conversation or request a quote.
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.